ATN�s
overall program coordination is governed by a Board of Directors.
Members currently on the board include:
Margaret L. Bauman, MD
Medical Chair, ATN
Associate Clinical
Professor of Neurology, Harvard Medical School; Associate Pediatrician
and Assistant Neurologist, Massachusetts General Hospital, Director of
LADDERS (Learning and Developmental Disabilities Evaluation and
Rehabilitation Service) which is a satellite clinic of the MassGeneral
Hospital for Children, and a branch of which is located at Giant Steps
Connecticut in Southport, CT. Director, The Autism Research Foundation,
Boston, MA and the Autism Research Consortium. Adjunct Associate
Professor, Department of Anatomy and Neurobiology, Boston University
School of Medicine, Boston, MA. Staff neurologist, Casa Colina Centers
for Rehabilitation, Inc, Pomona, California. Volunteer staff, Department
of Pediatrics, University of California at Irvine, Irvine, California.
Research interests include the study of the microscopic brain structure
in autism, Rett syndrome and other disorders of neurological
development. Co-editor of the book, "The Neurobiology of Autism" which
was published in l994 by Johns Hopkins University Press. Second edition
expected by November 2004.
Richard
Fade
Richard
Fade is the father of a 10 year old child with autism. Richard recently
retired as a Senior Vice President of Microsoft Corporation. He is
currently a venture partner at Ignition Partners LLC in Bellevue Washington.
Richard and partner Susan Fade have been active in promoting services
and intervention for individuals and families struggling with autism
since 1999. In 2000 the Fades created the endowment which established
the Autism Center at the University of Washington with Geraldine Dawson,
PhD becoming the center's director. Richard serves on the boards of
the Autism Center, and the Northwest Autism Foundation. The Fades
recently engaged in financing biomedical research in autism at Mass
General Hospital - and establishing a new organization - the Autism
Treatment Network - a network of institutions focused on improving
the standard of care for those with autism in the United States.
Gleason Eakin
President, Northwest Autism Foundation
David
K. Humphrey, JD
Mr. Humphrey
is a board member of the Northwest Autism Foundation (NWAF) whose
goal is to provide education and information about autism. For the
past five years Mr. Humphrey has devoted much of his time to the
research and study of autism, a growing global medical and health
issue. He has visited other countries such as Thailand, China and
North Korea to speak on the topic of autism. Mr. Humphrey is a successful
entrepreneur who has founded several companies in Oregon and Hawaii.
One of his companies was named for four consecutive years to Inc.
magazine's prestigious list of "500 Fastest Growing Companies
in the Nation."
James
M. Perrin, M.D.
James
M. Perrin, M.D., is professor of pediatrics at Harvard Medical School
and director of the Division of General Pediatrics and the Center
for Child and Adolescent Health Policy at the MassGeneral Hospital
for Children, a research and training center with an active fellowship
program in general pediatrics. He chaired the American Academy of
Pediatrics Committee on Children with Disabilities and is past president
of the Ambulatory Pediatric Association. For the American Academy
of Pediatrics, he also co-chaired a committee to develop practice
guidelines for attention deficit hyperactivity disorder. His research
has examined asthma, middle ear disease, children's hospitalization,
health insurance, and childhood chronic illness and disabilities,
with a recent emphasis on quality of life and use of primary and
subspecialty care for children and adolescents with chronic illness.
Dr. Perrin is the founding editor of Ambulatory Pediatrics, the
journal of the Ambulatory Pediatric Association. He served on the
Institute of Medicine's Committees on Maternal and Child Health
under Health Care Reform, Quality of Long-Term-Care Services in
Home and Community-Based Settings, and Enhancing Federal Healthcare
Quality Programs; the National Commission on Childhood Disability,
and the Disability Policy Panel of the National Academy of Social
Insurance (Chair, Children's Committee). He received a Robert Wood
Johnson Foundation Investigator Award in Health Policy Research.
He also served as a member of the Health Care Technology study section
of the Agency for Health Care Policy and Research and of the National
Advisory Council for the Agency for Healthcare Research and Quality.
Peter
H. Bell
Peter Bell is
the father of a 12 year old child with autism. Peter is currently
the Executive Director and CEO of Cure Autism Now, one of the largest
private funders of autism research in the world. Founded in 1995,
Cure Autism Now is an organization of parents, clinicians and leading
scientists committed to accelerating the pace of biomedical research
in autism through research, education and outreach. Bell joined
Cure Autism Now in 2004 following a successful 12-year marketing
career at McNeil Consumer & Specialty Pharmaceuticals, a member
of the Johnson & Johnson family of companies. Throughout his
career, Bell developed and marketed a variety of pharmaceutical
products including TYLENOL®, Children�s MOTRIN®, CONCERTA®,
and RISPERDAL®. Bell is also very active within the autism community.
He has served as the parent co-chair of the Research Committee for
The Autism Center at UMDNJ and was a founding member of the Philadelphia
Chapter of CAN. Bell and his family were also involved in the establishment
of the M.I.N.D. Institute at UC, Davis. Peter and his wife, Liz,
reside in Los Angeles, California with their three children.
|